Bigul

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2020

SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2021 ,inter alia, to consider and approve This is to inform you that the meeting of the Board of Directors of the Company will be held on Friday, January 29, 2021 to inter alia consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2020. Further, kindly note that pursuant to the Company''s Code of Conduct for Prevention of Insider Trading, the window closure for trading by Designated Persons, commenced on January 01, 2021, and shall end on January 31, 2021 i.e. after 48 hours of the declaration of financial results of the Company on January 29, 2021. This is for your information and record.
04-01-2021
Bigul

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 24, 2020 for Raksha Valia
24-12-2020
Bigul

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Closure of Trading Window

This is to inform you that in compliance with the Company's Code of Conduct for prevention of Insider Trading, the window closure for trading by Designated Persons of the Company (alongwith his/her immediate relatives or any person with whom he/she shares a material financial relationship), shall be with effect from Friday, 1st January, 2021 till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter and nine months ended 31st December, 2020. The date of the Board Meeting of the Company for declaration of the financial results for the quarter and nine months ended 31st December, 2020 will be intimated in due course.
23-12-2020
Bigul

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 21, 2020 for Aditya Medisales Ltd
21-12-2020
Bigul

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 21, 2020 for Shanghvi Finance Pvt Ltd
21-12-2020
Bigul

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Of Record Date For Redemption Of Commercial Paper

Please find enclosed Intimation of Record Date for Redemption of Commercial Paper.
18-12-2020

Buy Sun Pharmaceutical Industries: target of Rs 660 : Sharekhan

Sharekhan is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 660 in its research report dated December 14, 2020.
15-12-2020
Bigul

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 10, 2020 for Raksha Valia
10-12-2020
Bigul

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 07, 2020 for Shanghvi Finance Pvt Ltd
07-12-2020
Bigul

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 04, 2020 for Raksha Valia
04-12-2020
Next Page
Close

Let's Open Free Demat Account